Clinical Trial: Soluble Programmed Death 1 (sPD1) is a Diagnostic Biomarker of ILD in Patients With Rheumatoid Arthritis Disease

Press/Media: Press / Media

PeriodNov 4 2021

Media coverage

2

Media coverage

  • TitleClinical Trial: Soluble Programmed Death 1 (sPD1) is a Diagnostic Biomarker of ILD in Patients With Rheumatoid Arthritis Disease
    Media name/outletHealth Daily Digest (Ht Media)
    CountryIndia
    Date11/4/21
    PersonsOmar Mohammed Abdelsaboor
  • TitleClinical Trial: Soluble Programmed Death 1 (sPD1) is a Diagnostic Biomarker of ILD in Patients With Rheumatoid Arthritis Disease
    Media name/outletUS Fed News
    CountryUnited States
    Date11/4/21
    PersonsOmar Mohammed Abdelsaboor